RxDoctor Payments Data

Arwyn Taffs

Adult Health · Highlands Ranch, CONPI 1881035038

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (39.7%), education and food and beverage — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 71.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $1,315 and has fallen 79.2% since, to $274 in 2025. Among adult health clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,021in general payments, 2019–2025

Across 37 payments — averaging $81.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$2K
  • Amgen$260
  • Pfizer$108
  • Tactile Systems Technology Inc$105
  • E.r. Squibb & Sons, L.L.C.$91
  • Lilly USA, LLC$77
  • plus $233 from 7 others

What the payments were for

  • Food & beverage$87429%
  • Education$94731%
  • Other$1,20040%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,021 in reported general payments places this provider in the 90th percentile of 430 adult health providers in Colorado.

See all adult health providers in Colorado

Medicare billing

Part B allowed, 2024
$13,964
Medicare patients
128
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab28$362,794
RinvoqUpadacitinib14$88,000
Hydroxychloroquine Sulfate97$2,993
Febuxostat17$2,514
MethotrexateMethotrexate Sodium104$2,095
Leflunomide21$1,306
Prednisone52$313
Naproxen25$279
Gabapentin46$250
Duloxetine Hcl21$238
Celecoxib12$230
Meloxicam17$184
Tramadol Hcl22$77
Allopurinol11$61

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$30$88,00014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 430 adult health providers in Colorado.

Other adult health in Highlands Ranch

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →